Shenzhen Genuine Biomedical Technology Co., Ltd. was an indirect wholly-owned subsidiary of Genuine Biotech and had been principally engaged in R&D of drugs in areas with unmet medical needs such as hematological diseases, tumors, liver diseases, infectious diseases and cardiovascular diseases.